2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Advanced Lung Carcinoma: new trials by email Literature Review of Advanced Lung Carcinoma trials Research Report on Advanced Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer TQB3616 capsules, Anlotinib Hydrochloride capsules, Irinotecan Hydrochloride for Injection - Advanced Lung Carcinoma | Phase 2 | Terminated | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 21 | 2021-08-18 | 2026-04-13 |
| Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies Anti-CTLA4 Monoclonal Antibody BMS-986218, Nivolumab, Stereotactic Body Radiation Therapy - Advanced Lung Carcinoma, Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 13 | 2021-03-29 | 2026-03-03 |
Adrenal Gland Neoplasms (1) · Carcinoma, Hepatocellular (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1)
Adenocarcinoma (1) · Adrenal Gland Diseases (1) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Liver Diseases (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Pathologic Processes (1)
Injections (1) · Irinotecan (1) · Nivolumab (1) · Radiosurgery (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · M.D. Anderson Cancer Center (1)
China (1) · United States (1)
James Welsh (1)